title: Bronchial amyloidosis successfully treated with low-dose long-term erythromycin therapy.
abstract: A 69-year-old man was admitted for evaluation of an abnormal chest X-ray. A diagnosis of primary bronchial amyloidosis was made on the basis of the chest X-ray, CT scans and bronchial biopsy specimens. The patient was treated with low-dose long-term erythromycin therapy (600 mg/day). After four months of therapy, chest CT scans, bronchoscopic findings and bronchial biopsy specimens revealed significant improvement of inflammatory changes. Low-dose erythromycin therapy may be helpful in terms of its anti-inflammatory effects for patients with bronchial amyloidosis.
authors.affiliation: Department of Respiratory Medicine, National Kyusyu Medical Center, Fukuoka, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Nakahara
authors.forename: T
authors.initials: T
authors.lastname: Yano
authors.forename: Y
authors.initials: Y
authors.lastname: Oshita
authors.forename: Y
authors.initials: Y
authors.lastname: Shiga
authors.forename: H
authors.initials: H
authors.lastname: Koga
authors.forename: M
authors.initials: M
authors.lastname: Takeshita
authors.forename: K
authors.initials: K
authors.lastname: Oizumi
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001982:Bronchial Diseases / Q000000981:diagnostic imaging / Q000188:drug therapy*; D004917:Erythromycin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011859:Radiography
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin